cheminform abstract: asymmetric synthesis of quaternary carbon compounds via chiral bicyclic lactams

1995 organic chemistry, review organic chemistry, review Z 0200 28 - 296 Asymmetric Synthesis of Quaternary Carbon Compounds via Chiral Bicyclic Lactams — (22 refs.). — (MEYERS, A. I.; Semin. Org. Synth., Summer Sch. ”A. Corbella”, 17th 17 (1992) 145-162; Dep. Chem., Colo. State Univ., USA; EN) 1

Upload: a-i-meyers

Post on 10-Aug-2016

212 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: ChemInform Abstract: Asymmetric Synthesis of Quaternary Carbon Compounds via Chiral Bicyclic Lactams

1995 organic chemistry, review

organic chemistry, reviewZ 0200

28 - 296Asymmetric Synthesis of Quaternary Carbon Compounds via ChiralBicyclic Lactams — (22 refs.). — (MEYERS, A. I.; Semin. Org. Synth.,Summer Sch. ”A. Corbella”, 17th 17 (1992) 145-162; Dep. Chem., Colo. StateUniv., USA; EN)

Synthesis of [c]‐Fused Bicyclic Proline Analogues

Synthesis of Bicyclic Sulfones: Inhibitors of

SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF Β LACTAMS ...heteroletters.org/issue14/ReviewNo.1.pdf · SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF Β LACTAMS: ANTIBACTERIAL ACTIVITIES AND

Synthesis and structural chemistry of bicyclic hexaaza

Antibiotics & Beta Lactams

Molecular characterization of Quinolones and β-Lactams ... Medicine/Bacteriology... · 171 Molecular characterization of Quinolones and β-Lactams Resistant Salmonella Serovars Determinants

Ring-Expanded Bicyclic β-Lactams: A Structure Chiroptical

ChemInform Sheet A4 · 2013. 9. 13. · The ChemInform Reaction Library (CIRX) helps to deal with the enormous number of published reactions as it does not cover all information available

CLINICAL USE OF BETA-LACTAMS

Cell-Permeable Bicyclic Peptidyl Inhibitors against NEMO-IκB … › lindert.1 › wp-content › ... · 2019-09-18 · Cell-Permeable Bicyclic Peptidyl Inhibitors against NEMO-IκB

Therapeutic drug monitoring of -lactams · Therapeutic drug monitoring of b-lactams Frédéric Cotton Clinical Chemistry ... § inter-individual variability of pharmacokinetics §

Synthesis of New -Lactams Bearing the Biologically